\-\ Texto\\:\\ \ \(0\)\
\-\ urine\\ values\\:\ \(0\)\
\-\ \\ \\ normetanephrine\\ 24h\\:\\ 406\\ ug\\/24hr\\ \\ \\(53\\-310\\ ug\\/24hr\\)\ \(0\)\
\-\ \\ \\ metanephrine\\ 24h\\:\\ \\ \\ \\ 594\\ ug\\/24hr\\ \\ \\(95\\-475\\ ug\\/24hr\\)\ \(0\)\
\-\ surgical\\ resection\\ is\\ the\\ standard\\ curative\\ modality\\.\\ if\\ the\\ primary\\ tumor\\ is\\ localized\\ to\\ the\\ adrenal\\ gland\\ and\\ is\\ benign\\,\\ then\\ survival\\ is\\ that\\ of\\ the\\ normal\\ age\\-matched\\ population\\.\\ in\\ patients\\ with\\ unresectable\\,\\ recurrent\\,\\ or\\ metastatic\\ disease\\ long\\-term\\ survival\\ is\\ possible\\.\\ however\\,\\ the\\ overall\\ 5\\-year\\ survival\\ is\\ less\\ than\\ 50\\%\\.\\ pharmacologic\\ treatment\\ of\\ the\\ catecholamine\\ excess\\ is\\ mandatory\\ and\\ surgery\\,\\ radiation\\ therapy\\,\\ or\\ chemotherapy\\ may\\ provide\\ palliative\\ benefit\\.\ \(0\)\
\-\ dose\\:\\ 10\\.5\\ mci\\ iodine\\-123\\ mibg\\,\\ iv\\.\ \(0\)\
\-\ procedure\\:\\ after\\ pretreatment\\ with\\ sski\\ solution\\ to\\ block\\ uptake\\ in\\ the\\ thyroid\\ gland\\,\\ radiotracer\\ was\\ injected\\.\\ \\ 24\\ hour\\ delayed\\ planar\\ and\\ single\\ photon\\ emission\\ computed\\ tomography\\ \\(spect\\)\\ of\\ the\\ chest\\,\\ abdomen\\ and\\ pelvis\\ were\\ obtained\\.\ \(0\)\
\-\ findings\\:\\ \\ the\\ planar\\ images\\ demonstrated\\ normal\\ distribution\\ of\\ radiotracer\\ activity\\ and\\ no\\ uptake\\ identified\\ in\\ the\\ bilateral\\ adrenal\\ regions\\ \\(not\\ shown\\)\\.\\ \\ the\\ spect\\ images\\ demonstrate\\ in\\ three\\ orthogonal\\ tomographic\\ planes\\,\\ focal\\ uptake\\ in\\ the\\ bilateral\\ upper\\ retroperitoneal\\/adrenal\\ regions\\.\\ \\ there\\ are\\ no\\ other\\ areas\\ of\\ abnormal\\ radiotracer\\ accumulation\\.\ \(0\)\
\-\ bilateral\\ pheochromocytoma\ \(0\)\
\-\ pheochromocytoma\\ \ \(6\)\
\-\ neuroblastoma\ \(81\)\
\-\ ganglioneuro\\(blasto\\)ma\ \(0\)\
\-\ \\(ddx\\ for\\ imaging\\ findings\\ only\\)\ \(0\)\
\-\ 82\\ y\\/o\\ white\\ female\\ with\\ anxiety\\ attacks\\ and\\ labile\\ hypertension\\.\\ \\ \\ laboratory\\ values\\ consistent\\ with\\ pheochromocytoma\\.\\ \\ please\\ evaluate\\ with\\ nuclear\\ scintigraphy\ \(0\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.21403938933839792\ \(0\)\
\-\ survival\\:\\ 0\\.18478992708029893\ \(0\)\
\-\ 24h\\:\\ 0\\.18159172568059978\ \(0\)\
\-\ adrenal\\:\\ 0\\.17535971587467017\ \(0\)\
\-\ radiotracer\\:\\ 0\\.16527965093222374\ \(0\)\
\-\ the\\:\\ 0\\.15112373222267206\ \(0\)\
\-\ uptake\\:\\ 0\\.14559421456457503\ \(0\)\
\-\ spect\\:\\ 0\\.14427420755752446\ \(0\)\
\-\ planar\\:\\ 0\\.14194273495776175\ \(0\)\
\-\ is\\:\\ 0\\.12099048330508788\ \(0\)\
\-\ values\\:\\ 0\\.11643563984770068\ \(0\)\
\-\ regions\\:\\ 0\\.10833429828596929\ \(0\)\
\-\ gland\\:\\ 0\\.10254099287480362\ \(0\)\
\-\ bilateral\\:\\ 0\\.10176030238937071\ \(0\)\
\-\ sski\\:\\ 0\\.10093394313272688\ \(0\)\
\-\ ganglioneuro\\:\\ 0\\.10093394313272688\ \(0\)\
\-\ blasto\\:\\ 0\\.10093394313272688\ \(0\)\
\-\ labile\\:\\ 0\\.10093394313272688\ \(0\)\
\-\ 406\\:\\ 0\\.09644777113645406\ \(0\)\
\-\ catecholamine\\:\\ 0\\.09644777113645406\ \(0\)\
\-\ 594\\:\\ 0\\.0932647814501538\ \(0\)\
\-\ normetanephrine\\:\\ 0\\.09079586284029989\ \(0\)\
\-\ mandatory\\:\\ 0\\.09079586284029989\ \(0\)\
\-\ pretreatment\\:\\ 0\\.09079586284029989\ \(0\)\
\-\ metanephrine\\:\\ 0\\.08877860945388097\ \(0\)\
\-\ unresectable\\:\\ 0\\.08707304601767284\ \(0\)\
\-\ mibg\\:\\ 0\\.08707304601767284\ \(0\)\
\-\ pharmacologic\\:\\ 0\\.0855956197675807\ \(0\)\
\-\ photon\\:\\ 0\\.08429243745760814\ \(0\)\
\-\ orthogonal\\:\\ 0\\.08312670115772679\ \(0\)\
\-\ solution\\:\\ 0\\.08110944777130788\ \(0\)\
\-\ attacks\\:\\ 0\\.08110944777130788\ \(0\)\
\-\ emission\\:\\ 0\\.08022383432026074\ \(0\)\
\-\ in\\:\\ 0\\.07850428781432792\ \(0\)\
\-\ and\\:\\ 0\\.07825112344758103\ \(0\)\
\-\ tomographic\\:\\ 0\\.0754575394751537\ \(0\)\
\-\ ma\\:\\ 0\\.0754575394751537\ \(0\)\
\-\ curative\\:\\ 0\\.07391117679316216\ \(0\)\
\-\ excess\\:\\ 0\\.07391117679316216\ \(0\)\
\-\ anxiety\\:\\ 0\\.07255467263768765\ \(0\)\
\-\ mci\\:\\ 0\\.07213710377876223\ \(0\)\
\-\ block\\:\\ 0\\.07060857230373598\ \(0\)\
\-\ injected\\:\\ 0\\.06895411409246197\ \(0\)\
\-\ palliative\\:\\ 0\\.06806850064141483\ \(0\)\
\-\ benefit\\:\\ 0\\.06698820307904177\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.06554298722004569\ \(0\)\
\-\ planes\\:\\ 0\\.06510035773539562\ \(0\)\
\-\ 82\\:\\ 0\\.06426492242716492\ \(0\)\
\-\ provide\\:\\ 0\\.06386972822000453\ \(0\)\
\-\ modality\\:\\ 0\\.062416592345260646\ \(0\)\
\-\ findings\\:\\ 0\\.06229914713755473\ \(0\)\
\-\ with\\:\\ 0\\.06179311271496943\ \(0\)\
\-\ of\\:\\ 0\\.06175621339218328\ \(0\)\
\-\ tomography\\:\\ 0\\.06113233948648746\ \(0\)\
\-\ accumulation\\:\\ 0\\.06098180299389392\ \(0\)\
\-\ computed\\:\\ 0\\.060833287186453866\ \(0\)\
\-\ ddx\\:\\ 0\\.059981770099916315\ \(0\)\
\-\ hour\\:\\ 0\\.05984601058651723\ \(0\)\
\-\ population\\:\\ 0\\.059711896683521594\ \(0\)\
\-\ nuclear\\:\\ 0\\.059711896683521594\ \(0\)\
\-\ dose\\:\\ 0\\.0589396581199749\ \(0\)\
\-\ standard\\:\\ 0\\.05857285342801597\ \(0\)\
\-\ images\\:\\ 0\\.05838938440695885\ \(0\)\
\-\ overall\\:\\ 0\\.0579873061376764\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.0579873061376764\ \(0\)\
\-\ localized\\:\\ 0\\.05669680493112894\ \(0\)\
\-\ urine\\:\\ 0\\.05649563099762109\ \(0\)\
\-\ distribution\\:\\ 0\\.05353922113779921\ \(0\)\
\-\ please\\:\\ 0\\.0529450240565497\ \(0\)\
\-\ normal\\:\\ 0\\.05153851433104729\ \(0\)\
\-\ recurrent\\:\\ 0\\.05060704498113509\ \(0\)\
\-\ procedure\\:\\ 0\\.050318144455103304\ \(0\)\
\-\ thyroid\\:\\ 0\\.04960050943547033\ \(0\)\
\-\ delayed\\:\\ 0\\.04938874676992066\ \(0\)\
\-\ evaluate\\:\\ 0\\.049078513506108826\ \(0\)\
\-\ shown\\:\\ 0\\.04892659906201873\ \(0\)\
\-\ single\\:\\ 0\\.048531404854858344\ \(0\)\
\-\ hypertension\\:\\ 0\\.048291389770095165\ \(0\)\
\-\ activity\\:\\ 0\\.046337633037299986\ \(0\)\
\-\ laboratory\\:\\ 0\\.04583197245883048\ \(0\)\
\-\ iv\\:\\ 0\\.0450965349228431\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.044815522699664344\ \(0\)\
\-\ 24\\:\\ 0\\.04474637084001489\ \(0\)\
\-\ identified\\:\\ 0\\.04474637084001489\ \(0\)\
\-\ then\\:\\ 0\\.04467764849779201\ \(0\)\
\-\ obtained\\:\\ 0\\.04464344673477013\ \(0\)\
\-\ pelvis\\:\\ 0\\.0441427159696084\ \(0\)\
\-\ 50\\:\\ 0\\.044077631890601\ \(0\)\
\-\ factoid\\:\\ 0\\.044077631890601\ \(0\)\
\-\ or\\:\\ 0\\.043912872567271895\ \(0\)\
\-\ benign\\:\\ 0\\.04335545215748742\ \(0\)\
\-\ less\\:\\ 0\\.042937883298562\ \(0\)\
\-\ areas\\:\\ 0\\.04285041832507564\ \(0\)\
\-\ possible\\:\\ 0\\.04276363935844242\ \(0\)\
\-\ three\\:\\ 0\\.042367434208659266\ \(0\)\
\-\ radiation\\:\\ 0\\.04182495980314238\ \(0\)\
\-\ white\\:\\ 0\\.041641207464241346\ \(0\)\
\-\ no\\:\\ 0\\.04104828228697309\ \(0\)\
\-\ resection\\:\\ 0\\.04045726266590681\ \(0\)\
\-\ only\\:\\ 0\\.0394304052088862\ \(0\)\
\-\ see\\:\\ 0\\.03926115890267753\ \(0\)\
\-\ primary\\:\\ 0\\.038808653918965305\ \(0\)\
\-\ demonstrated\\:\\ 0\\.038788518769591725\ \(0\)\
\-\ abdomen\\:\\ 0\\.03851040778757408\ \(0\)\
\-\ abnormal\\:\\ 0\\.0379183906416143\ \(0\)\
\-\ focal\\:\\ 0\\.03775228518036644\ \(0\)\
\-\ however\\:\\ 0\\.03735644824402249\ \(0\)\
\-\ if\\:\\ 0\\.036671135636202085\ \(0\)\
\-\ therapy\\:\\ 0\\.03626341590357718\ \(0\)\
\-\ than\\:\\ 0\\.03577785729982782\ \(0\)\
\-\ patients\\:\\ 0\\.035505399336320735\ \(0\)\
\-\ metastatic\\:\\ 0\\.034615186316915014\ \(0\)\
\-\ consistent\\:\\ 0\\.034222170614312035\ \(0\)\
\-\ surgery\\:\\ 0\\.03393306419750311\ \(0\)\
\-\ upper\\:\\ 0\\.03372745063290324\ \(0\)\
\-\ chest\\:\\ 0\\.03331507017338226\ \(0\)\
\-\ imaging\\:\\ 0\\.03316884432442918\ \(0\)\
\-\ tumor\\:\\ 0\\.033012583824029836\ \(0\)\
\-\ demonstrate\\:\\ 0\\.03281151741858685\ \(0\)\
\-\ other\\:\\ 0\\.03277641132400311\ \(0\)\
\-\ were\\:\\ 0\\.03253373894131077\ \(0\)\
\-\ may\\:\\ 0\\.03176124352631311\ \(0\)\
\-\ to\\:\\ 0\\.031557038805374346\ \(0\)\
\-\ surgical\\:\\ 0\\.030675741526744973\ \(0\)\
\-\ after\\:\\ 0\\.030617914244270926\ \(0\)\
\-\ female\\:\\ 0\\.030455692756195103\ \(0\)\
\-\ treatment\\:\\ 0\\.030064820331456858\ \(0\)\
\-\ that\\:\\ 0\\.02738935801063258\ \(0\)\
\-\ disease\\:\\ 0\\.026493255798963736\ \(0\)\
\-\ there\\:\\ 0\\.02511309292729449\ \(0\)\
\-\ not\\:\\ 0\\.02491613228535652\ \(0\)\
\-\ are\\:\\ 0\\.02394911021510636\ \(0\)\
\-\ was\\:\\ 0\\.021996053733461966\ \(0\)\
\-\ for\\:\\ 0\\.019129542848169756\ \(0\)\
